Literature DB >> 10517276

A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats.

E D Milligan1, J L Hinde, K K Mehmert, S F Maier, L R Watkins.   

Abstract

A method for direct catheterization of the lumbar subarachnoid space has recently been developed by Storkson et al. (1996) (J Neurosci Methods 1996;65:167-172) that may potentially improve upon the widely used method of Yaksh and Rudy (1976) (Physiol Behav 1976;17:1031-1036). This 'catheter-through-a-needle' technique inserts the catheter between lumbar vertebrae 5 (L5) and 6 (L6), which has been shown to reduce neurological impairment and post-surgical deaths. However, employing this technique allows the external portion of the chronic indwelling catheters to be easily damaged, resulting in approximately 50% attrition within 4 days after surgery. Therefore, we developed an easy and inexpensive method for protecting the external portion of the catheter that enhances catheter viability beyond 14 days after catheter implantation while also maintaining a low injection volume (8 microl). Moreover, this modification does not significantly alter the implantation methods developed by Storkson et al. (1996) (J Neurosci Methods 1996;65:167-172) and allows for more optimal catheter materials to be incorporated. Chronically implanted catheters (n = 70) with the external portion of the catheter protected, resulted in 4% attrition 7 days after surgery and 11% attrition 14 days after surgery. Approximately 5.5% of animals implanted showed very mild and transient neurological impairment.

Entities:  

Mesh:

Year:  1999        PMID: 10517276     DOI: 10.1016/s0165-0270(99)00075-8

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  40 in total

1.  Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120.

Authors:  Diana K Schoeniger-Skinner; Annemarie Ledeboer; Matthew G Frank; Erin D Milligan; Stephen Poole; David Martin; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2007-01-03       Impact factor: 7.217

2.  An MD2 hot-spot-mimicking peptide that suppresses TLR4-mediated inflammatory response in vitro and in vivo.

Authors:  Liping Liu; Nilanjan Ghosh; Peter F Slivka; Zeno Fiorini; Mark R Hutchinson; Linda R Watkins; Hang Yin
Journal:  Chembiochem       Date:  2011-06-15       Impact factor: 3.164

3.  Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Daniel J Urban; Xiaohui Wang; Michael V Baratta; Timothy J Fabisiak; Nathan D Anderson; Kejun Cheng; Lisa I Greene; Debra Berkelhammer; Yingning Zhang; Amanda L Ellis; Hang Hubert Yin; Serge Campeau; Kenner C Rice; Bryan L Roth; Steven F Maier; Linda R Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

4.  Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming.

Authors:  Leah E Hains; Lisa C Loram; Julie L Weiseler; Matthew G Frank; Erik B Bloss; Paige Sholar; Frederick R Taylor; Jacqueline A Harrison; Thomas J Martin; James C Eisenach; Steven F Maier; Linda R Watkins
Journal:  J Pain       Date:  2010-10       Impact factor: 5.820

5.  Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines.

Authors:  E D Milligan; K A O'Connor; K T Nguyen; C B Armstrong; C Twining; R P Gaykema; A Holguin; D Martin; S F Maier; L R Watkins
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

6.  MicroRNA-124 and microRNA-146a both attenuate persistent neuropathic pain induced by morphine in male rats.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Steven F Maier; Linda R Watkins
Journal:  Brain Res       Date:  2018-05-01       Impact factor: 3.252

7.  Clonidine reduces hypersensitivity and alters the balance of pro- and anti-inflammatory leukocytes after local injection at the site of inflammatory neuritis.

Authors:  Alfonso Romero-Sandoval; James C Eisenach
Journal:  Brain Behav Immun       Date:  2006-10-31       Impact factor: 7.217

8.  Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).

Authors:  Mark R Hutchinson; Yingning Zhang; Kimberley Brown; Benjamen D Coats; Mitesh Shridhar; Paige W Sholar; Sonica J Patel; Nicole Y Crysdale; Jacqueline A Harrison; Steven F Maier; Kenner C Rice; Linda R Watkins
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

9.  Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats.

Authors:  Erin D Milligan; Carin Twining; Marucia Chacur; Joseph Biedenkapp; Kevin O'Connor; Stephen Poole; Kevin Tracey; David Martin; Steven F Maier; Linda R Watkins
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta.

Authors:  S S Lewis; M R Hutchinson; N Rezvani; L C Loram; Y Zhang; S F Maier; K C Rice; L R Watkins
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.